We are live on
!
Find out more
PCM
Portolan Capital Management Portfolio holdings
AUM
$1.88B
1-Year Est. Return
115.74%
This Fund
S&P 500
This Quarter
Est. Return
+63.96%
1 Year Est. Return
+115.74%
3 Year Est. Return
+581.85%
5 Year Est. Return
+1,047.01%
10 Year Est. Return
+13,266.68%
AUM
$876M
AUM Growth
+$209M
(+31%)
Cap. Flow
-$55M
Cap. Flow
% of AUM
-6.28%
Top 10 Holdings %
Top 10 Hldgs %
24.02%
Holding
154
New
42
Increased
32
Reduced
54
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LPRO
Open Lending Corp
LPRO
|
+$11.9M |
| 2 |
Stride
LRN
|
+$11.8M |
| 3 |
Sportsman's Warehouse
SPWH
|
+$11.2M |
| 4 |
Dick's Sporting Goods
DKS
|
+$10.5M |
| 5 |
Crocs
CROX
|
+$10.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LivePerson
LPSN
|
+$17.4M |
| 2 |
Akamai
AKAM
|
+$16.8M |
| 3 |
Qualys
QLYS
|
+$13.6M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$13M |
| 5 |
eHealth
EHTH
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.98% |
| 2 | Consumer Discretionary | 15.83% |
| 3 | Consumer Staples | 14.05% |
| 4 | Healthcare | 12.61% |
| 5 | Communication Services | 11.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Castle Biosciences
CSTL
$979M
| $2.71M | 0.31% |
71,834
-63,820
| -47% | -$2.18M |
|
102
Ollie's Bargain Outlet
OLLI
$4.94B
| $2.68M | 0.31% |
27,464
-7,172
| -21% | -$551K |
|
103
Dollar Tree
DLTR
$25.2B
| $2.58M | 0.29% |
27,831
-72,831
| -72% | -$6.07M |
|
|
ICAD
104
DELISTED
iCAD Inc
ICAD
| $2.52M | 0.29% |
252,514
+91,638
| +57% | +$990K |
|
|
DZSI
105
DELISTED
DZS Inc. Common Stock
DZSI
| $2.46M | 0.28% |
+275,004
| New | +$1.83M |
|
|
HDS
106
DELISTED
HD Supply Holdings, Inc.
HDS
| $2.42M | 0.28% |
+69,971
| New | +$2.17M |
|
107
Western Digital
WDC
$150B
| $2.42M | 0.28% |
72,514
-79,378
| -52% | -$2.57M |
|
108
Haemonetics
HAE
$4B
| $2.4M | 0.27% |
26,747
+625
| +2% | +$63.1K |
|
109
Beyond Air
XAIR
$3.86M
| $2.07M | 0.24% |
+715
| New | +$2.21M |
|
|
ABMD
110
DELISTED
Abiomed Inc
ABMD
| $2.02M | 0.23% |
8,385
-3,770
| -31% | -$757K |
|
|
CFRX
111
DELISTED
ContraFect Corporation
CFRX
| $1.97M | 0.22% |
+3,847
| New | +$1.89M |
|
|
PFSW
112
DELISTED
PFSweb, Inc.
PFSW
| $1.89M | 0.22% |
+282,432
| New | +$1.5M |
|
113
Harvard Bioscience
HBIO
$29.2M
| $1.8M | 0.21% |
+57,929
| New | +$1.56M |
|
114
LendingTree
TREE
$451M
| $1.75M | 0.2% |
6,046
-473
| -7% | -$114K |
|
115
Etsy
ETSY
$7.85B
| $1.71M | 0.2% |
+16,123
| New | +$1.19M |
|
|
CHRA
116
DELISTED
Charah Solutions, Inc Common Stock
CHRA
| $1.59M | 0.18% |
+49,951
| New | +$866K |
|
117
Quantum Corp
QMCO
$474M
| $1.5M | 0.17% |
19,484
-11,886
| -38% | -$941K |
|
118
Vicor
VICR
$10.2B
| $1.45M | 0.17% |
20,165
-14,193
| -41% | -$797K |
|
|
TWTR
119
DELISTED
Twitter, Inc.
TWTR
| $1.07M | 0.12% |
35,866
-127,501
| -78% | -$3.84M |
|
|
DSKE
120
DELISTED
Daseke, Inc. Common Stock
DSKE
| $956K | 0.11% |
+243,142
| New | +$535K |
|
|
HRC
121
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $934K | 0.11% |
8,509
-65,703
| -89% | -$6.88M |
|
|
SCTL
122
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $835K | 0.1% |
+183,554
| New | +$1.14M |
|
|
EBIX
123
DELISTED
Ebix Inc
EBIX
| $751K | 0.09% |
33,594
-99,988
| -75% | -$2.06M |
|
124
Magnite
MGNI
$3.55B
| $526K | 0.06% |
78,787
-203,755
| -72% | -$1.27M |
|
125
Unisys
UIS
$217M
| $485K | 0.06% |
44,463
-315,759
| -88% | -$3.65M |
|
Similar funds
JPG
SGF
TF
VC
PCP
EPW
P3I
LPU
Portolan Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Portolan Capital Management held 154 positions worth $876M, up 31% from $667M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Portolan Capital Management withdrew a net $55M in Q2 2020, closing 26 positions and reducing 54 holdings. Its most notable exit was eHealth, an estimated $12.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, Portolan Capital Management opened a new position in Open Lending Corp worth $15.8M.
- Portolan Capital Management's largest Q2 2020 buy was Open Lending Corp: 1,049,006 shares worth $15.8M.
- Portolan Capital Management added most to Stride in Q2 2020, an estimated $11.8M increase.
- Portolan Capital Management's biggest Q2 2020 reduction was LivePerson, cutting an estimated $17.4M.
- Portolan Capital Management fully exited eHealth in Q2 2020, selling an estimated $12.8M.
- Portolan Capital Management's ten largest holdings make up 24% of its $876M portfolio in Q2 2020.
- Portolan Capital Management opened 42 new positions and closed 26 in Q2 2020.
- Portolan Capital Management's portfolio value rose 31% quarter-over-quarter to $876M.
Based on Portolan Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.